Arrivent Biopharma Inc. logo

Arrivent Biopharma Inc. (AVBP)

Market Open
9 Dec, 17:36
NASDAQ (NMS) NASDAQ (NMS)
$
24. 99
+0.01
+0.04%
$
929.61M Market Cap
- P/E Ratio
0% Div Yield
89,917 Volume
- Eps
$ 24.98
Previous Close
Day Range
24.7 25.29
Year Range
15.47 29.71
Want to track AVBP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 83 days
Name Time Cons. EPS Eps
Arrivent Biopharma Inc. logo
AVBP Arrivent Biopharma Inc.
2 Mar 2026 (In 2 months)
-
-
Arrivent Biopharma Inc. logo
AVBP Arrivent Biopharma Inc.
13 Nov 2025
-
-
Arrivent Biopharma Inc. logo
AVBP Arrivent Biopharma Inc.
12 Nov 2025
-
-
Arrivent Biopharma Inc. logo
AVBP Arrivent Biopharma Inc.
10 Nov 2025
-
-
Arrivent Biopharma Inc. logo
AVBP Arrivent Biopharma Inc.
13 Aug 2025
-
-
Arrivent Biopharma Inc. logo
AVBP Arrivent Biopharma Inc.
12 May 2025
-
-
Arrivent Biopharma Inc. logo
AVBP Arrivent Biopharma Inc.
27 Mar 2025
-
-
Arrivent Biopharma Inc. logo
AVBP Arrivent Biopharma Inc.
14 Nov 2024
-
-
Arrivent Biopharma Inc. logo
AVBP Arrivent Biopharma Inc.
15 Aug 2024
-
-
Arrivent Biopharma Inc. logo
AVBP Arrivent Biopharma Inc.
8 May 2024
-
-
Arrivent Biopharma Inc. logo
AVBP Arrivent Biopharma Inc.
29 Mar 2024
-
-

AVBP Earnings Reports FAQ

What is the earnings per share (EPS) for AVBP?

EPS data for AVBP is currently not available, as Arrivent Biopharma Inc has not reported recent earnings.

What is the company's earnings growth rate?

Arrivent Biopharma Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

The next earnings release is expected to be on 2026-03-02, based on the AVBP's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Arrivent Biopharma Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for AVBP at this time, as Arrivent Biopharma Inc has no recent EPS data to calculate it.